Abnova is the world's largest antibody manufacturer. They have the capacity of generating 300 mouse monoclonal antibodies and 200 rabbit polyclonal antibodies every month. Rather than the traditional method of antibody production, Abnova uses a genomic/proteomic approach for the antibody development. The goal is to have at least one antibody to every human expressed gene in human genome. All of Abvona’s products, including their recombinant proteins and antibodies, are manufactured in state-of-the-art production and SPF animal facilities. Abnova also has multiple clones for each monoclonal antibody target, and these are available to partners and collaborators from both academia and industry.